Vimarsana
Biggest News Aggregation in the World

Page 2 - Brain Cognitive Development Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain Cognitive Development Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Cognitive Development Study Today - Breaking & Trending Today

Social media use and sleep duration connected to brain activity in teens - Vimarsana News

Social media use and sleep duration connected to brain activity in teens

A new study found a distinct relationship between sleep duration, social media usage, and brain activation across brain regions that are key for executive control and reward processing.

Study: Some kids are already using online dating apps at age 11 - Vimarsana News

Study: Some kids are already using online dating apps at age 11

US and Canadian researchers have been studying the use of dating sites by minors, and have observed that some preteens, particularly those aged 11 and 12, are already using these platforms or applications to find love.

Altered Subcortico-Cortical Connectivity Among Children and Adolescents With ADHD - Vimarsana News

Altered Subcortico-Cortical Connectivity Among Children and Adolescents With ADHD

Among children and adolescents with ADHD, brain activity in the circuits between subcortical regions and the cortex are altered.

Altered Subcortico-Cortical Connectivity Among Children and Adolescents With ADHD - Vimarsana News

Altered Subcortico-Cortical Connectivity Among Children and Adolescents With ADHD

Among children and adolescents with ADHD, brain activity in the circuits between subcortical regions and the cortex are altered.

2 Minute Medicine Rewind April 8, 2024 | 2 Minute Medicine - Vimarsana News

2 Minute Medicine Rewind April 8, 2024 | 2 Minute Medicine

Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial 2. Patients randomized to receive and addition of sitagliptin to insulin therapy provided non-critically ill hospitalized patients with type 2 diabetes (T2DM) better glycemic control and higher mean daily glucose level